Oxygen affinity
Reversible binding and the local pO₂ gradient govern release. Historical HBOC-201 is reported near P50 40 mmHg at 37°C; BHOC-specific characterization is required.
Oxygen availability and metabolic demand change across the transplant journey. The research task is to characterize the carrier and measure whether organ function can be supported under defined conditions.
Hemoglobin binds oxygen reversibly and releases it as local oxygen pressure falls. This inherent molecular behavior is central to the BHOC Transplant research concept; the device and clinical protocol determine how much carrier reaches the tissue.
Reversible binding and the local pO₂ gradient govern release. Historical HBOC-201 is reported near P50 40 mmHg at 37°C; BHOC-specific characterization is required.
Test carrier function during cooling, cold support and gradual rewarming. P50 and release change with temperature, pH and formulation; P50 ≈ 40 is not a constant from 4 to 37°C.
Match carrier concentration and perfusion conditions to each stage. Measure extraction, ATP, lactate, vascular resistance and organ-specific function against controls.
As local pO₂ falls, hemoglobin’s binding equilibrium favors oxygen release. Choose a demand state to see the idea. The dots are a schematic, not a measured BHOC dose or release curve.
Illustrative interface only. No clinical units or claimed response time.
At a lower local pO₂, carrier saturation falls and oxygen can unload. The amount also depends on affinity, dose, flow, pH and temperature.
Track P50/oxygen curves, kinetics, methemoglobin and vascular response at defined temperatures throughout cooling and rewarming.
Measure energy state, viable operating window, organ-specific output and post-transplant recovery against controls.